Emerging evidence shows the involvement of Hsp90 in tumor immunity and the potential of enhancing immunotherapy with Hsp90i, although the mechanisms remain inadequately characterized and all these studies used pan-Hsp90i. The gene discussed is HSP90AB1; the disease is neoplasm.